The efficacy of adherence treatment and commitment to fear from a recurrence of cancer and post-traumatic growth in patients with breast cancer.
Not Applicable
- Conditions
- breast cancer.Malignant neoplasm of breast
- Registration Number
- IRCT2017062225732N19
- Lead Sponsor
- Semnan University of Medical Sciences, Deputy of Research and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Cancer detection by oncologist; at least education to middle school.
Exclusion criteria: Patients who have concurrent medical disorders; patients are undergoing another psychotherapy at the same time; patients who have severe disease or another cancer.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fear of cancer recurrence. Timepoint: The middle of treatment, after treatment and two months after the end of treatment. Method of measurement: Questionnaire fear of cancer recurrence.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie adherence treatment's impact on fear of cancer recurrence in breast cancer patients?
How does commitment therapy compare to standard psychological interventions for post-traumatic growth in breast cancer survivors?
Are there specific biomarkers that predict response to adherence treatment and commitment therapy in malignant breast neoplasm?
What adverse events are associated with adherence treatment and commitment therapy in breast cancer populations?
What combination approaches enhance post-traumatic growth outcomes alongside fear of recurrence reduction in breast cancer patients?